Featured

Regimens based on ibrutinib alone and lenalidomide and rituximab in combination show high activity in patients with relapsed or refractory mantle cell lymphoma. We hypothesised that the combination of all three drugs would improve efficacy compared with previously published...

Standfirst:Collaborations between academia, industry and government are increasingly creating the kinds of fertile environments where health innovation can sprout and flourish. Singapore’s thriving entrepreneurial, start-up environment is a case in point. Singapore’s government has recognised the value of innovative thought...

The adoption of mobile technology within healthcare environments has increased significantly in recent years, as more and more clinicians turn to their devices to coordinate care and manage patient health outcomes. With an estimated 95% of Americans now owning...

As part of its ongoing commitment to patient safety, EvergreenHealth has partnered with Clorox Healthcare to bring advanced ultraviolet light disinfecting technology to the health system's existing patient safety and infection-fighting protocols. The Clorox Healthcare® Optimum-UV Enlight® System will...

Cancer patients in the U.K. will gain access to the country’s first Varian Halcyon™ radiotherapy treatment devices when the first of two systems are delivered to Queen’s Hospital near London later this month. The Halcyon systems from Varian Medical...

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute announced the first patients have begun treatment in a new pancreatic cancer multi-center clinical trial. To combat the nation’s third deadliest cancer, the phase 1b/2 open-label study will explore...

The InterVapor® Bronchoscopic Thermal Vapor Ablation (BTVA®) is back on the market after a brief hiatus as the asset sale of Uptake Medical Corporation was being completed to Broncus Holding Co. A new company, Uptake Medical Technology, Inc was...